Details
Stereochemistry | ACHIRAL |
Molecular Formula | Al |
Molecular Weight | 26.9815 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Al]
InChI
InChIKey=AZDRQVAHHNSJOQ-UHFFFAOYSA-N
InChI=1S/Al.3H
Molecular Formula | Al |
Molecular Weight | 26.9815 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Aluminum is an element with an atomic number of 13. On the periodic table of elements its symbol is Al. It belongs to a group of metals including lead and tin. Aluminum has been used for a long time. During Ancient Egypt, aluminum oxides were used in their glazes and pottery. The Romans also used this metallic element. During the 1800s, advances in research made it possible to produce pure aluminum.
Aluminium is used in a huge variety of products including cans, foils, kitchen utensils, window frames, beer kegs and aeroplane parts. This is because of its particular properties. It has low density, is non-toxic, has a high thermal conductivity, has excellent corrosion resistance and can be easily cast, machined and formed. It is also non-magnetic and non-sparking. It is the second most malleable metal and the sixth most ductile. It is often used as an alloy because aluminium itself is not particularly strong. Alloys with copper, manganese, magnesium and silicon are lightweight but strong. They are very important in the construction of aeroplanes and other forms of transport. Aluminium is a good electrical conductor and is often used in electrical transmission lines. It is cheaper than copper and weight for weight is almost twice as good a conductor. When evaporated in a vacuum, aluminium forms a highly reflective coating for both light and heat. It does not deteriorate, like a silver coating would. These aluminium coatings have many uses, including telescope mirrors, decorative paper, packages and toys. Aluminium has no known biological role. Aluminium can accumulate in the body, and a link with Alzheimer’s disease has been suggested but not proven. Aluminum-containing raw materials are used safely and extensively in cosmetics, pharmaceuticals and over-the-counter (OTC) drug products. In cosmetics, they function as pigments and thickening agents. Aluminum compounds also function as active ingredients in OTC drugs such as antacids and antiperspirants. Aluminum-containing ingredients have several uses in cosmetics and personal care products. Aluminum salts are used as antiperspirants to control sweat. Antiperspirant ingredients are regulated as over-the-counter (OTC) drugs by the U.S. Food and Drug Administration (FDA). A manufacturer can only use the aluminum active ingredients that have been approved as safe and effective by the FDA as listed in the OTC antiperspirant monograph. These products can only be used according to the guidelines established in this monograph. Aluminum may also be present in cosmetic colors. Aluminum powder is FDA approved and may be safely used in coloring externally applied cosmetics, including cosmetics intended for use in the area of the eye, [21 CFR §73.2645 Aluminum powder.]. In addition, aluminum is a common component in other cosmetic colors where it may be used as a substrate upon which another color is precipitated. Because the resulting color is not water-soluble, this can prevent ‘bleeding’, for example with lipstick. There are other uses of aluminum-containing ingredients in cosmetics, such as use as thickening agents. Under federal law, the safety of all ingredients must be substantiated by the manufacturer of the product before it is placed on the market. Aluminum compounds (alum) are the most widely used adjuvants in veterinary and human vaccines. Alum facilitates effectiveand long-lasting protective immunity in hosts, mainly by inducing antibody responses. Alum was found toinduce endogenous CD4+T cells and antibody production as well as to induce priming of CD8+T cells. These effects are shown to beindependent of the inflammasome. Novel findings of unexpected beneficial effects of decreased HBV (Hepatitis B virus) viral load and HBeAg seroconversion in chronically infected patients, as well as significant tumor suppression in experimental mice following multiple alum-only injections were examined, revealing alum's potential clinical applications beyond its use as a simple tool in antigen preparation.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Thrombocytopenia associated with intravenous desferrioxamine. | 1985 Oct |
|
Age related decline in aluminum-activated human platelet adenylate cyclase: post-receptor changes in cyclic AMP second messenger signal amplification in normal aging and dementia of the Alzheimer type. | 1986 Sep 29 |
|
Effects of long-term in vitro exposure to aluminum, cadmium or lead on differentiation and cholinergic receptor expression in a human neuroblastoma cell line. | 1987 Dec |
|
Grand mal fitting in a patient on regular haemodialysis treatment and receiving desferrioxamine therapy. | 1988 |
|
Aluminum neurotoxicity: altered expression of cytoskeletal genes. | 1988 Apr |
|
Exacerbation of aluminium encephalopathy after treatment with desferrioxamine. | 1989 |
|
Neuronal gene expression in aluminum myelopathy. | 1989 Mar |
|
Cerebrospinal fluid aluminum levels following deferoxamine. | 1990 Aug |
|
[Environmental factors in western Pacific foci of ALS and a possible pathogenetic role of aluminum (Al) in motor neuron degeneration]. | 1991 Dec |
|
Dose-dependent effects of aluminum on osteocalcin synthesis in osteoblast-like ROS 17/2 cells in culture. | 1992 Dec |
|
Comparative binding study of aluminum and chromium to human transferrin. Effect of iron. | 1992 Jan-Mar |
|
Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. | 1993 Jan 15 |
|
[D-Pen2,D-Pen5]enkephalin, a delta opioid agonist reduces endogenous aluminum content in the rat central nervous system. | 1995 May |
|
Inhibition of transcription factor IIIA-DNA interactions by xenobiotic metal ions. | 1996 Mar 1 |
|
Aluminum alters iron and manganese uptake and regulation of surface transferrin receptors in primary rat oligodendrocyte cultures. | 1996 May 6 |
|
Neuronal gene expression in aluminum-induced neurofibrillary pathology: an in situ hybridization study. | 1997 |
|
Zinc allosterically modulates antagonist binding to cloned D1 and D2 dopamine receptors. | 1997 May |
|
Effects of aluminum on activity of krebs cycle enzymes and glutamate dehydrogenase in rat brain homogenate. | 2000 May |
|
Bronchial hyperreactivity in patients who inhale heroin mixed with cocaine vaporized on aluminum foil. | 2002 Apr |
|
Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice. | 2002 Jul |
|
The degradation of Abeta(25-35) by the serine protease plasmin is inhibited by aluminium. | 2002 Oct |
|
Molecular understanding of aluminum-induced topological changes in (CCG)12 triplet repeats: relevance to neurological disorders. | 2002 Oct 9 |
|
Differential toxicity of nitric oxide, aluminum, and amyloid beta-peptide in SN56 cholinergic cells from mouse septum. | 2003 Mar |
|
Aluminum exchange between citrate and human serum transferrin and interaction with transferrin receptor 1. | 2003 Mar 18 |
|
Aluminium-induced impairment of Ca2+ modulatory action on GABA transport in brain cortex nerve terminals. | 2003 Sep 15 |
|
Elevated levels of ferrimagnetic metals in foodchains supporting the Guam cluster of neurodegeneration: do metal nucleated crystal contaminants [corrected] evoke magnetic fields that initiate the progressive pathogenesis of neurodegeneration? | 2004 |
|
Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopmental toxins and thimerosal. | 2004 Apr |
|
The effect of cations on the amidase activity of human tissue kallikrein: 1-linear competitive inhibition by sodium, potassium, calcium and magnesium. 2-linear mixed inhibition by aluminium. | 2004 Aug |
|
Aluminum decreases the glutathione regeneration by the inhibition of NADP-isocitrate dehydrogenase in mitochondria. | 2004 Dec 15 |
|
Antioxidants prevent aluminum-induced toxicity in cultured hepatocytes. | 2004 Jun |
|
A novel cation-sensing mechanism in osteoblasts is a molecular target for strontium. | 2004 May |
|
Effect of metal cations on the conformation and inactivation of recombinant human factor VIII. | 2004 Oct |
|
Serum Clara cell protein as an indicator of pulmonary impairment in occupational exposure at aluminum foundry. | 2006 |
|
Evidence for centrophenoxine as a protective drug in aluminium induced behavioral and biochemical alteration in rat brain. | 2006 Oct |
|
Aluminum complexing enhances amyloid beta protein penetration of blood-brain barrier. | 2006 Oct 20 |
|
Phenotype-dependent susceptibility of cholinergic neuroblastoma cells to neurotoxic inputs. | 2006 Sep |
|
Involvement of oxidative stress in the impairment in biliary secretory function induced by intraperitoneal administration of aluminum to rats. | 2007 Jun |
|
Impact of aluminum on the oxidation of lipids and enzymatic lipolysis in monomolecular films at the air/water interface. | 2007 Mar 13 |
|
An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration. | 2007 Sep |
|
[Selection of bax siRNA sequences and its influence on aluminum induced glioma cell apoptosis]. | 2008 May |
|
Aluminum and silica in drinking water and the risk of Alzheimer's disease or cognitive decline: findings from 15-year follow-up of the PAQUID cohort. | 2009 Feb 15 |
|
Physiological, molecular, and cellular mechanisms of impaired seawater tolerance following exposure of Atlantic salmon, Salmo salar, smolts to acid and aluminum. | 2010 Aug 1 |
|
Microsomal Ca2+ flux modulation as an indicator of heavy metal toxicity. | 2010 Jul |
|
Absence of binding between the human transferrin receptor and the transferrin complex of biological toxic trace element, aluminum, because of an incomplete open/closed form of the complex. | 2010 Sep |
|
A novel approach for a toxicity prediction model of environmental pollutants by using a quantitative structure-activity relationship method based on toxicogenomics. | 2011 |
|
The disruption of L-carnitine metabolism by aluminum toxicity and oxidative stress promotes dyslipidemia in human astrocytic and hepatic cells. | 2011 Jun 24 |
|
[The effects of caspase-3 siRNA on the neurobehavior of mice exposed to aluminum]. | 2011 May |
|
Molecular dynamics simulations of iron- and aluminum-loaded serum transferrin: protonation of Tyr188 is necessary to prompt metal release. | 2012 Sep 4 |
|
How aluminum adjuvants could promote and enhance non-target IgE synthesis in a genetically-vulnerable sub-population. | 2013 Apr-Jun |
|
Assessment of infantile mineral imbalances in autism spectrum disorders (ASDs). | 2013 Nov 11 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27004761
In the phase II B clinical trial, 74 hepatitis B virus patients with a viral load 4100 000 copies/mL and a serum ALT (alanine transaminase) oftwo to ten times the upper limit of normal were injected with 1 mL 0.1% Aluminum emulsion intramuscularly once every four weeks, for a total of six injections.
Route of Administration:
Intramuscular
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Jun 26 00:22:55 UTC 2021
by
admin
on
Sat Jun 26 00:22:55 UTC 2021
|
Record UNII |
CPD4NFA903
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 178.3297
Created by
admin on Sat Jun 26 00:22:55 UTC 2021 , Edited by admin on Sat Jun 26 00:22:55 UTC 2021
|
||
|
WHO-ATC |
D10AX01
Created by
admin on Sat Jun 26 00:22:55 UTC 2021 , Edited by admin on Sat Jun 26 00:22:55 UTC 2021
|
||
|
CFR |
21 CFR 176.170
Created by
admin on Sat Jun 26 00:22:55 UTC 2021 , Edited by admin on Sat Jun 26 00:22:55 UTC 2021
|
||
|
DSLD |
264 (Number of products:9)
Created by
admin on Sat Jun 26 00:22:55 UTC 2021 , Edited by admin on Sat Jun 26 00:22:55 UTC 2021
|
||
|
EPA PESTICIDE CODE |
111
Created by
admin on Sat Jun 26 00:22:55 UTC 2021 , Edited by admin on Sat Jun 26 00:22:55 UTC 2021
|
||
|
NCI_THESAURUS |
C637
Created by
admin on Sat Jun 26 00:22:55 UTC 2021 , Edited by admin on Sat Jun 26 00:22:55 UTC 2021
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
7429-90-5
Created by
admin on Sat Jun 26 00:22:55 UTC 2021 , Edited by admin on Sat Jun 26 00:22:55 UTC 2021
|
PRIMARY | |||
|
7429-90-5
Created by
admin on Sat Jun 26 00:22:55 UTC 2021 , Edited by admin on Sat Jun 26 00:22:55 UTC 2021
|
PRIMARY | |||
|
D000535
Created by
admin on Sat Jun 26 00:22:55 UTC 2021 , Edited by admin on Sat Jun 26 00:22:55 UTC 2021
|
PRIMARY | |||
|
DB01370
Created by
admin on Sat Jun 26 00:22:55 UTC 2021 , Edited by admin on Sat Jun 26 00:22:55 UTC 2021
|
PRIMARY | |||
|
1311504
Created by
admin on Sat Jun 26 00:22:55 UTC 2021 , Edited by admin on Sat Jun 26 00:22:55 UTC 2021
|
PRIMARY | RxNorm | ||
|
M1589
Created by
admin on Sat Jun 26 00:22:55 UTC 2021 , Edited by admin on Sat Jun 26 00:22:55 UTC 2021
|
PRIMARY | Merck Index | ||
|
5359268
Created by
admin on Sat Jun 26 00:22:55 UTC 2021 , Edited by admin on Sat Jun 26 00:22:55 UTC 2021
|
PRIMARY | |||
|
507
Created by
admin on Sat Jun 26 00:22:55 UTC 2021 , Edited by admin on Sat Jun 26 00:22:55 UTC 2021
|
PRIMARY | |||
|
C68232
Created by
admin on Sat Jun 26 00:22:55 UTC 2021 , Edited by admin on Sat Jun 26 00:22:55 UTC 2021
|
PRIMARY | |||
|
CPD4NFA903
Created by
admin on Sat Jun 26 00:22:55 UTC 2021 , Edited by admin on Sat Jun 26 00:22:55 UTC 2021
|
PRIMARY | |||
|
INS-173
Created by
admin on Sat Jun 26 00:22:55 UTC 2021 , Edited by admin on Sat Jun 26 00:22:55 UTC 2021
|
PRIMARY | |||
|
231-072-3
Created by
admin on Sat Jun 26 00:22:55 UTC 2021 , Edited by admin on Sat Jun 26 00:22:55 UTC 2021
|
PRIMARY | |||
|
SUB12808MIG
Created by
admin on Sat Jun 26 00:22:55 UTC 2021 , Edited by admin on Sat Jun 26 00:22:55 UTC 2021
|
PRIMARY | |||
|
SUB130454
Created by
admin on Sat Jun 26 00:22:55 UTC 2021 , Edited by admin on Sat Jun 26 00:22:55 UTC 2021
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |